KPTI - Karyopharm Therapeutics EPS misses by $0.07 misses on revenue May, 05 2020 07:04 AM Karyopharm Therapeutics Inc. Karyopharm Therapeutics (NASDAQ:KPTI): Q1 GAAP EPS of -$0.78 misses by $0.07.More news on: Karyopharm Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...